Related Experiment Video
Updated: May 20, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Peripartum cardiomyopathy
Uri Elkayam1, Sawan Jalnapurkar, Mohamad Barakat
1Division of Cardiology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. elkayam@usc.edu
Cardiology Clinics
|July 21, 2012
Summary
Peripartum cardiomyopathy (PPCM) is a rare form of heart failure. Recent European guidelines update the definition of PPCM, improving diagnosis and management for pregnant women.
Area of Science:
- Cardiology
- Maternal Health
- Heart Failure
Background:
- Peripartum cardiomyopathy (PPCM) was first defined in 1971 by Demakis et al. based on specific clinical criteria.
- The original PPCM criteria are now recognized as arbitrary, and the condition can manifest earlier in pregnancy.
- A European Society of Cardiology working group has recently updated the definition of PPCM.
Purpose of the Study:
- To discuss the updated definition, causes, clinical presentation, prognosis, and treatment of peripartum cardiomyopathy (PPCM).
- To provide a comprehensive overview of PPCM, including related aspects.
Main Methods:
- Review and synthesis of existing literature and guidelines.
- Discussion based on the European Society of Cardiology's updated PPCM working group criteria.
- Exploration of etiological factors, clinical manifestations, and therapeutic strategies.
Main Results:
- The definition of PPCM has been refined to better capture earlier presentations and arbitrary criteria.
- The article covers the multifaceted aspects of PPCM, from etiology to management.
Conclusions:
- Updated diagnostic criteria for PPCM are crucial for timely and accurate diagnosis.
- Comprehensive understanding and management of PPCM are essential for improving maternal and cardiac outcomes.
- Further research into PPCM etiology and treatment is warranted.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...